Tinnitus News

In a recent study published in The Laryngoscope researchers assessed the incidence of new-onset tinnitus after coronavirus disease 2019 (COVID-19) vaccination. The growing prevalence of vaccine hesitancy and anxiety about the messenger ribonucleic acid (mRNA) COVID-19 vaccine’s side effects has become an important global health concern. In the present study, researchers determined the proportion of patients who […]

In a recent study published in The Laryngoscope researchers assessed the incidence of new-onset tinnitus after coronavirus disease 2019 (COVID-19) vaccination. The growing prevalence of vaccine hesitancy and anxiety about the messenger ribonucleic acid (mRNA) COVID-19 vaccine's side effects has become an important global health concern.

The results of the second randomised controlled trial (RCT) examining the efficacy of the Lenire tinnitus therapy system have now been published in the respected journal "Nature - Scientific Reports".

New AI-enabled hearing aids from Starkey can help isolate sounds that a user would prefer to hear from complex background noise.

A new “real-word”, 20 patient study (Buechner et al 2022) investigating the effectiveness of Lenire in alleviating tinnitus symptoms has been shown that over a 6-12 week treatment period, 86.2% of participants reported a clinically significant improvement in their tinnitus Nb id rather say 8 out of 10 than 86.2%.

Biotech company Frequency Therapeutics is seeking to reverse hearing loss with a new form of regenerative therapy.

Visual Snow Syndrome (VSS) is an uncommon (estimated prevalence of around 2% in the UK) neurological condition that causes individuals to see black, white or transparent dots in their field of vision.

Starkey Hearing Technologies have just launched a new product range that is specifically designed to be used by audiologists in order to improve hearing whilst having the capability to provide bespoke tinnitus sound therapy.

Starkey Hearing Technologies have just launched a new product range that is specifically designed to be used by audiologists in order to improve hearing whilst having the capability to provide bespoke tinnitus sound therapy.

This paper describes the results from a double blinded randomised control trial examining the efficacy of bimodal neuromodulation for the treatment of bothersome subjective tinnitus.

There has been an awareness in the audiology world since March 2020, that some patients who have reported having COVID 19 also report an increase in tinnitus symptoms.

Tinnitus has been strongly linked to Covid-19 after a new study found the symptom was mentioned by a large proportion of those infected with the virus.